capital on and the uncertainty from These have will are indeed purchases. unprecedented healthcare times, and Thank sometime in impact the hello, an COVID-XX you, market everyone. for equipment Dow,
will As was in EMEA. see and believe current fiscal COVID-XX the our due of the last visibility, construction. delaying we performance lockdowns access restricting our we March year orders impact quarter second-half the to Mike on in when be started mentioned, of and until to bulk Based ahead sites revenues our Americas of to stressed and year second
followed our quarter, lockdowns. believe this fourth a our in improvement fiscal sequential by impact wave infections quarter, have assuming in of will We higher second fiscal or no third
oncology market as an me oncology Care share in the Portfolio. Cancer and radiation with Let the overarching are positioned we and leader trends expanding across how see we
Let’s start with the market.
and patient treatment is such mammograms, procedures, treatment prostate procedure. elective cancer in new delays starts, radiological cancer exams While considered an have screenings, slowed as elective not itself
significant negative As it without can the time to only delayed such, for patient. short be a consequences period of
a saw saw oncology patient Of in the no respondents compared or patient in XX% change study, change volumes, April the States radiation to To the and pandemic criticality this published report since illustrated marginal a increase United treatment where was Advisory for surgery, the volumes. or the Group. only increase marginal increased end, no radiation in again, by the in of cancer the in field this XX% has XXXX therapy
As the a new pandemic short-term. therapy radiation significantly period see during resume expect of and average daily will treatments stabilizes increase we other and catch-up cancer in the volumes which U.S. procedures the to screening in markets,
access remains radiation Moving to to the customers. customers, continues with a best on the have latest solutions and Based of priority, market. our portfolio to interactions Varian oncology in solutions the
have foreign I of limitations, through in Orders continued to are and currency orders. the some what around and will we uncertainty headwinds, expect April, lockdowns you through late seeing March from trends in budget delays walk we each geography. drive pandemic
the Americas In million order portion a had saw late the America March, due delay of North largest orders $XX of new to we during COVID-XX. delays. in these approximately
when return it early to While order pre-pandemic it too April, activity estimate resumed is levels. in will to
in of budget of America restrictions America. recovery We the closely We critical are follow North the will currently of that allocations lockdown capital step, a as Latin believe removal first with along hospitals. monitoring
where customer behavior the XX pandemic. the varied country EMEA, severity had by growth we’ve orders by the quarters, strong last has and In over of
strong. Germany, For example, in activity remains
However, that the from in we and new and Italy, Spain impact COVID-XX affect believe equipment orders. will tenders
India, days. of lockdown the equipment has our of momentarily the expansion demand XX In and cancer substantially care activity the for over strong, past remains extension impacted while
China’s stabilization. radiation most were daily being Pacific, issuances on average tender new volumes globally to have oncology close in treatment return inpatient remotely seeing levels. due where volumes indicating to China, levels, average resumed systems, pre-pandemic Asia procedure, Within to pre-pandemic an are monitored we treatment affected Further
Japan, it post of state conversations and active some towards China many recovery new tender we placement. cautiously In the is that we is sustainable. tenders continue closely seen being emergency, slow, while have and are optimistic customer order tracked
remains of fiscal in challenges will of These second-half a to some access Turning variation, installations challenging. backlog geographic timing With certain site impact and conversion. be logistical headwind and customer moderate readiness XXXX. the will
trainings installations leveraging teams navigated and continue exceedingly globe around possible, have where the technologies. Our well including remote to
example, these six challenges in second dissipate. April. our to delayed China, contained, This For as accelerator quarter, pandemic in installs us leads of the experience in the completed fiscal that XX believe is will were
We believe criticality installed well by contracts, long-term services radiation driven as treatments. service are reasonably oncology of COVID-XX, large and insulated as our from the base
customers. sites to globally engineers service service to access Our critical continue provide our to
also this assurance treatment support great team’s ability evidenced by us increase all focus services through markets. well positioned our Our major is an other services Score Net Promoter our during in in customer technology-enabled time, have quality and to CTSI remotely. planning,
to high more decision In capital upfront purchase the Proton will delays due Solutions, outlay, likely pronounced. be
grow continue backlog will stable expect We to execute our on and services and projects in be time. over to
have near-term decreased Finally, cases, patients trends early-stage volumes. drive with our in regional hospitals cancer Interventional to has while patients including been impacted advanced Solutions, cancer treatments, deferred, local these We treatment ablation embolization. interventional will procedures access have continued believe pressure their stage across portfolio. for In many
geographies. resumption the by and encouraged EMEA Americas are in We of procedure the
are headwinds there summary, In impact will near-term that this.
cancer in estimated patient for XX patients we believe in see XX to as new million total XXXX However, XXXX, market, market from well-positioned are innovation we increase in million in a long-term impact. in growth will leader which the care an
let’s that, go Q&A. Operator? With to
